28th February 2023Assessing Pretomanid for Tuberculosis (APT)The paper discussed in today's episode: Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results